About CFL Pharmaceuticals Limited
Data last updated:
CFL Pharmaceuticals Limited is a public limited company based in Goa, India. It operates in the brokerage and trading services segment of the financial services sector. It was incorporated on 30 September 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Goa, under CIN U24246GA1981PLC000465. Its GSTIN is 24AAACC7387H1ZK (Gujarat). The company holds 9 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹75 Lakh. It was formerly known as Cosme Farma Laboratories Limited. It is led by directors including Maryann Veronica Menezes (Whole-Time Director) and Christine Stephanie Menezes (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dempo Towers 5th Floor Edc Patto Plaza Panjim, Goa, India – 403001.
As per the financials filed for FY 2025, the company reported a revenue of ₹201.84 Cr, a decline of 26% compared to the previous year. For the same year it recorded a net profit of ₹41.91 Cr (net margin 20.8%) and EBITDA of ₹48.27 Cr (EBITDA margin 23.9%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 26% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹128.83 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cflpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressDempo Towers 5th Floor Edc Patto Plaza Panjim, Goa, India – 403001
- IndustryFinancial Services, Brokerage & Trading Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of CFL Pharmaceuticals Limited
CFL Pharmaceuticals has one previous CIN (Corporate Identification Number): U24246GA1981PTC000465. The current CIN is U24246GA1981PLC000465, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24246GA1981PLC000465 | Current |
| U24246GA1981PTC000465 | Previous |
Business Activity of CFL Pharmaceuticals Limited
The main business activity of CFL Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of CFL Pharmaceuticals Limited
CFL Pharmaceuticals Limited is audited by M/S Shilpa Deshpande & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M/S Shilpa Deshpande & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of CFL Pharmaceuticals Limited
CFL Pharmaceuticals has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maryann Veronica Menezes Also directs: Menezes Pharmaceuticals Limited, Frederick Electro Devices Private Limited, Cosme Bio-Tech Private Limited and 2 more | Whole-Time Director | 30 Nov 2012 | 13 Years 10 Months | Current |
| Christine Stephanie Menezes Also directs: Menezes Pharmaceuticals Limited, Frederick Electro Devices Private Limited, Cosme Bio-Tech Private Limited and 2 more | Whole-Time Director | 10 Apr 2013 | 13 Years 5 Months | Current |
| Brenda Juliette Nazareth Menezes Also directs: Menezes Pharmaceuticals Limited, Frederick Electro Devices Private Limited, Cosme Bio-Tech Private Limited and 2 more | Director | 30 Oct 2013 | 12 Years 11 Months | Current |
Financials of CFL Pharmaceuticals Limited FY 2025 filings available
CFL Pharmaceuticals Limited reported revenue of ₹201.84 Cr (down 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of CFL Pharmaceuticals Limited
Revenue fell 26% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 26%. EBITDA fell 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of CFL Pharmaceuticals Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹48.27 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹41.91 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of CFL Pharmaceuticals Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 20.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of CFL Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of CFL Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of CFL Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Apr 2012 | Bank of India | ₹10.65 Cr | Satisfied |
| 19 May 2009 | Bank of India | ₹10.65 Cr | Satisfied |
| 11 Sep 2007 | Bank of India | ₹10.65 Cr | Satisfied |
| 11 Sep 2007 | Bank of India | ₹30 Lakh | Satisfied |
| 16 Mar 2005 | Bank of India | ₹18.36 Lakh | Satisfied |
Total charge records: 25 View all charges
Employees and EPFO Compliance at CFL Pharmaceuticals Limited
CFL Pharmaceuticals Limited has a workforce of 12 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of CFL Pharmaceuticals Limited
CFL Pharmaceuticals has 9 GST registrations: 1 active and 8 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACC7387H1ZK | Gujarat | Active | 06 Nov 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for CFL Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by CFL Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of CFL Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of CFL Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on CFL Pharmaceuticals Limited
Frequently Asked Questions about CFL Pharmaceuticals Limited
CFL Pharmaceuticals is an active public limited company based in Goa, India. The company works in brokerage and trading services, within the financial services industry. It was incorporated on 30 September 1981 (45+ years old) and is registered under CIN U24246GA1981PLC000465.
CFL Pharmaceuticals reported revenue of ₹201.84 Cr for FY 2025 (down 26% YoY).
CFL Pharmaceuticals has 3 current directors:
- Maryann Veronica Menezes - Whole-Time Director
- Christine Stephanie Menezes - Whole-Time Director
- Brenda Juliette Nazareth Menezes - Director
CFL Pharmaceuticals reported a net profit of ₹41.91 Cr (net margin 20.8%) and EBITDA of ₹48.27 Cr (EBITDA margin 23.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of CFL Pharmaceuticals is 29% over three years and 26% over five years. In the latest year (FY 2025) revenue fell 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of CFL Pharmaceuticals is 24AAACC7387H1ZK, registered in Gujarat. The company has 9 GST registrations in all, of which 1 is active and 8 are cancelled or inactive.
The CIN (Corporate Identification Number) of CFL Pharmaceuticals is U24246GA1981PLC000465. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
CFL Pharmaceuticals was incorporated on 30 September 1981, making it 45+ years old. It is registered with the Registrar of Companies, Goa.
CFL Pharmaceuticals can be reached through the website cflpharma.com. Its registered office is in Goa, India.